Articles by Fouad
Activity
-
The FDA approved the 50th #biosimilar this week. Congratulations from the Biosimilars Council and the Association for Accessible Medicines and thank…
The FDA approved the 50th #biosimilar this week. Congratulations from the Biosimilars Council and the Association for Accessible Medicines and thank…
Liked by Fouad Atouf
-
This is a big achievement, and I am proud to have been a part of this since the first biosimilar approval back in 2015. Everyone involved - from FDA…
This is a big achievement, and I am proud to have been a part of this since the first biosimilar approval back in 2015. Everyone involved - from FDA…
Liked by Fouad Atouf
-
Honored to host Dr. Lusiola at USP, and looking forward to continued conversations on how USP and Kenya BioVax Institute can work together to…
Honored to host Dr. Lusiola at USP, and looking forward to continued conversations on how USP and Kenya BioVax Institute can work together to…
Liked by Fouad Atouf
Publications
-
COVID-19 vaccine platforms: Delivering on a promise?
Human vaccines & immunotherapeutics
-
Do Standards Matter? What is Their Value?
Journal of Pharmaceutical Sciences
Languages
-
Arabic
Native or bilingual proficiency
-
French
Native or bilingual proficiency
-
English
Full professional proficiency
More activity by Fouad
WATCH the third installment of the ASGCT-Biotechnology Innovation Organization (BIO) Cell + Gene Therapy Science Series!
Hosted by FDA and led…
![]()
WATCH the third installment of the ASGCT-Biotechnology Innovation Organization (BIO) Cell + Gene Therapy Science Series! Hosted by FDA and led…
Liked by Fouad Atouf
Gillian Woollett, Samsung Bioepis at #festivalofbiologicsusa: However cheaply we make these #biosimilars, "it is irrelevant if we can’t commercialize…
![]()
Gillian Woollett, Samsung Bioepis at #festivalofbiologicsusa: However cheaply we make these #biosimilars, "it is irrelevant if we can’t commercialize…
Liked by Fouad Atouf
FDA is ready to eliminate the interchangeability designation for biosimilars via Endpoints News
Sarah Yim, director of the FDA’s Office of…
![]()
FDA is ready to eliminate the interchangeability designation for biosimilars via Endpoints News Sarah Yim, director of the FDA’s Office of…
Liked by Fouad Atouf
Excited to share the official meeting report for the IABS - International Alliance for Biological Standardization Vaccine Quality conference held…
![]()
Excited to share the official meeting report for the IABS - International Alliance for Biological Standardization Vaccine Quality conference held…
Liked by Fouad Atouf
The topics for my Quality Quarterly newsletters emerge from compelling conversations with colleagues or clients. I typically cover some technical…
![]()
The topics for my Quality Quarterly newsletters emerge from compelling conversations with colleagues or clients. I typically cover some technical…
Liked by Fouad Atouf
It is time for policymakers to ensure patients have access to lower-cost biosimilars. Read more from Executive Director Juliana "Julie" Reed in STAT…
![]()
It is time for policymakers to ensure patients have access to lower-cost biosimilars. Read more from Executive Director Juliana "Julie" Reed in STAT…
Liked by Fouad Atouf
How do global supply chain disruptions affect the availability of medicines, clinicians and patients? How can we address systemic vulnerabilities…
![]()
How do global supply chain disruptions affect the availability of medicines, clinicians and patients? How can we address systemic vulnerabilities…
Liked by Fouad Atouf
C-Path’s Critical Path for Parkinson’s Consortium is paying special tribute to the more than 10 million people around the world living with…
![]()
C-Path’s Critical Path for Parkinson’s Consortium is paying special tribute to the more than 10 million people around the world living with…
Liked by Fouad Atouf
“Standards have been shown to increase regulatory confidence, reduce the cost of developing medicines, which unlocks resources for innovation, and…
![]()
“Standards have been shown to increase regulatory confidence, reduce the cost of developing medicines, which unlocks resources for innovation, and…
Liked by Fouad Atouf
Recently, I had the opportunity to share insights underscoring the inextricable link between quality standards and the future of biologics and…
![]()
Recently, I had the opportunity to share insights underscoring the inextricable link between quality standards and the future of biologics and…
Shared by Fouad Atouf
What an incredible way to make a difference. Because of USP’s Expert Volunteers, more people can get the meds and dietary supplements they need and…
![]()
What an incredible way to make a difference. Because of USP’s Expert Volunteers, more people can get the meds and dietary supplements they need and…
Liked by Fouad Atouf
If you thought her presentation last month concerning ICH updates was great, register to attend the NJPQCA April Monthly Meeting where Janeen…
![]()
If you thought her presentation last month concerning ICH updates was great, register to attend the NJPQCA April Monthly Meeting where Janeen…
Liked by Fouad Atouf
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More